USPTO serial 99724076
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 12, 2026
The USPTO examiner issued a descriptiveness refusal for your mark, a specimen refusal for Class 35, and requested clarification on the service descriptions in Class 44.
B Pharma Inc.
Atlanta, GA, US
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and cloud-based software using artificial intelligence for patient engagement, medication adherence monitoring, and automated healthcare communication in the field of HIV prevention. | ACTIVE | Mar 25, 2026 |
| 035 | Business management and administration services, namely, managing patient communication and engagement programs on behalf of healthcare providers, clinics, and public health organizations in the field of HIV prevention. | ACTIVE | Mar 25, 2026 |
| 042 | Providing temporary use of non-downloadable software featuring artificial intelligence for patient engagement, medication adherence monitoring, and automated communication in the field of HIV prevention and sexual health. | ACTIVE | Mar 25, 2026 |
| 044 | Providing healthcare information, patient support services, and treatment adherence support in the field of HIV prevention and sexual health. | ACTIVE | Mar 25, 2026 |
| Date | Code | Event |
|---|---|---|
| Aug 12, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 12, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Aug 12, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Aug 5, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jul 29, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 25, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Mar 25, 2026 | NWAP | NEW APPLICATION ENTERED |